Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Well-established antiparasitic agent now reported to possess potent antitumor activity

Oct. 21, 2002

Novel antiproliferative macrolides prepared by Kosan researchers

Oct. 21, 2002

Antitumor activity of IDN-5109 against hormone-refractory prostate cancer

Oct. 21, 2002

Antimyeloma efficacy of PS-341 in a human plasmacytoma xenograft model

Oct. 21, 2002

Three series of MMP inhibitors prepared and tested at former Warner-Lambert

Oct. 21, 2002

Antiangiogenic effects of zoledronic acid demonstrated in vitro and in vivo

Oct. 18, 2002

Novel anticancer therapy: paclitaxel combined with an MEK inhibitor enhances apoptosis

Oct. 18, 2002

Inhibition of breast cancer cell growth in vitro with c-myc oligonucleotides and ICI-182780

Oct. 18, 2002

Verteporfin + PDT assessed as multiple basal cell carcinoma treatment in phase III trials

Oct. 17, 2002

Clinical trials begin in Boehringer Ingelheim and ImmunoGen anticancer collaboration

Oct. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...